TigaTx will use the ARPA-H and NIH funding to progress its lead program, TIGA-001, an IgA anti-EGFR neutrophil engager, into the clinic and generate clinical proof-of-concept data for its engineered ...
Neutrophils are an important part of your immune system. They’re a type of white blood cell that kills and eats bacteria and fungi to help your body fight infections and heal wounds. There are many ...
Neutropenia is a condition that develops when a person does not have enough neutrophils, which are a type of white blood cell. It is a common side effect of chemotherapy. Most cases of ...
Neutropenia is the most common serious risk of cancer treatment. It occurs when white blood cells called neutrophils drop below a healthy range, putting you at increased risk of infections.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results